Glucagon-like peptide 1 in the pathophysiology and pharmacotherapy of clinical obesity

Figure 2 Projected trends in National Health Service costs from a micro-simulation model. A computer based micro-simulation model[18] predicted the direct healthcare related costs of overweight and obesity in the United Kingdom at five time points from 2001 (2001, 2007, 2015, 2025 and 2050) should prevalence of overweight and obesity remain constant (red) or if an average of an 8-point BMI reduction was achieved in all those obese in 2001 (grey). BMI: Body mass index; NHS: National Health Service.